Skip to content

Med-stat.info

The latest health news

  • Coronavirus
  • Biotech
  • Health Tech
  • First Opinion
  • In the Lab
  • Pharma
Main Menu

Biotech

Biotech / Coronavirus

Pfizer’s Paxlovid study fails to answer key questions over benefit for broader populations

14.06.2022

Pfizer said Tuesday that a much-watched study of its antiviral Paxlovid in patients who have Covid but don’t have risk factors for severe disease failed to show a benefit in …

Read More
Biotech

Eli Lilly wins FDA approval for first-ever treatment for hair loss caused by autoimmunity

13.06.2022

The Food and Drug Administration on Monday approved an Eli Lilly drug that is the first-ever treatment for alopecia areata, an autoimmune disorder that triggers sudden hair loss. The once-daily …

Read More
Biotech

FDA advisers unanimously endorse Bluebird’s gene therapy for rare disorder

10.06.2022

Advisers to the Food and Drug Administration voted unanimously in favor of approving an investigational gene therapy from Bluebird Bio on Thursday, concluding that its benefits for children with a …

Read More
Biotech / Coronavirus

Moderna says Omicron-containing booster outperforms current vaccine

08.06.2022

Moderna said Wednesday that using a new version of its Covid-19 vaccine as a booster led to a superior antibody response against the Omicron variant compared to its current shot. …

Read More
Biotech

With the right molecular signal, a cancer drug works in every patient

05.06.2022

Sascha Roth was in her late 30s and feeling great. Then she noticed some bleeding when she used the bathroom. She went to see a gastroenterologist, who diagnosed her with …

Read More
Biotech

FDA approves Lilly diabetes drug that analysts expect to be a big seller

14.05.2022

The Food and Drug Administration said Friday it had approved Mounjaro, a new injection for type 2 diabetes made by Eli Lilly that lowers blood sugar and can help patients …

Read More
Biotech / Coronavirus / Health

Paxlovid’s failure as a preventative measure raises questions, but doctors still back it as a therapeutic

02.05.2022

Pfizer released news late Friday that Paxlovid, the antiviral currently subject to a big push from the U.S. government, failed to prevent people living with Covid patients from catching the …

Read More
Biotech / First Opinion

Opinion: If there is a digital health bubble, does it really matter for entrepreneurs?

19.04.2022

For the better part of the last two-plus years, my colleagues and I at 7wireVentures have been asked as investors if health care — and especially digital health — is …

Read More
Biotech

In the wake of big patent decision, it’s business as usual for CRISPR therapy developers

31.03.2022

NEW YORK — Earlier this month, the U.S. Patent and Trademark Office ruled that CRISPR patents key to developing human therapies belong to the Broad Institute of MIT and Harvard, …

Read More

Posts navigation

1 2 … 9 Next
Copyright © Med-stat.info
  • Terms of Service
  • Privacy Policy